2022-11-15T17:33:51-06:00 2021-12-31 111986323 MARCUM LLP 1899 L STREET NW SUITE 850 WASHINGTON DC 20036 990 2021-01-01 520880522 FOUNDATION FOR CONTEMPORARY MENTAL HEALTH FOUN 2022967100 2112 F STREET NW 404 WASHINGTON DC 20037 DR HOWARD HOFFMAN PRESIDENT/CEO 2022967100 2022-11-15 1 DR HOWARD HOFFMAN 999009999 AARON M FOX P01365820 2022274000 2022-11-15 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z DR HOWARD HOFFMAN 2112 F STREET NW 404 WASHINGTON DC 20037 2095055 0 X N/A X 1967 DC TO PROVIDE SUBSTANCE ABUSE TREATMENT AND EDUCATION IN THE WASHINGTON METROPOLITAN AREA. 5 4 35 5 0 0 217570 500581 3729722 819501 3187 774973 0 0 3950479 2095055 0 0 0 0 2874629 741021 0 0 0 1269157 434320 4143786 1175341 -193307 919714 1524794 1862366 825572 132 699222 1862234 FOUNDATION FOR CONTEMPORARY MENTAL HEALTH (THE FOUNDATION) IS ORGANIZED TO PROVIDE SUBSTANCE ABUSE TREATMENT AND EDUCATION IN THE WASHINGTON METROPOLITAN AREA WITH A SPECIAL INTEREST IN SERVING INDIGENT, UNINSURED AND UNDER-INSURED POPULATIONS. 0 0 945252 819501 PIDARC IS A PRIVATE, NON-PROFIT, OUTPATIENT MEDICATION ASSISTANT TREATMENT (MAT) PROGRAM LOCATED IN METROPOLITAN WASHINGTON, DC. IN 2021, WE PROVIDED METHADONE TREATMENT AND COUNSELING SERVICES TO PATIENTS WITH OPIOID USE DISORDERS, MOST OF WHOM ARE UNINSURED OR UNDERINSURED INDIVIDUALS. IN ADDITION, PIDARC REMAINED COMMITTED TO PROVIDING LINKAGES FOR PATIENTS TO ADDRESS THEIR MEDICAL AND PSYCHOSOCIAL NEEDS. 22350 DISTRICT OPIOID TARGETED STRATEGIES - IN 2021 THE FOUNDATION UTILIZED A GRANT FROM THE DEPARTMENT OF BEHAVIORAL HEALTH FOR THE PURPOSE OF IDENTIFYING PATIENTS TO RECEIVE COMPREHENSIVE PHYSICALS, EKGS AND TB TESTS ANNUALLY AND LINKING THEM WITH PRIMARY CARE AND SPECIALTY SERVICES. THE GRANT PAID FOR SALARIES, BENEFITS AND ASSOCIATED OPERATIONAL AND ADMINISTRATIVE COSTS FOR TWO INDIVIDUALS TO WORK WITH THE PATIENTS ON A CASE MANAGEMENT BASIS TO SCHEDULE AND FOLLOW UP ON THEIR PARTICIPATION WHILE ALSO COLLECTING REQUIRED DATA. 967602 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 9 0 35 1 0 0 0 0 0 0 0 0 0 0 0 0 X 5 4 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 0 0 DC X AUDREY CANNAMELA 2022967100 2112 F STREET NW 404 WASHINGTON DC 20037 DR HOWARD HOFFMAN PRESIDENT/CEO 40.00 X X 174327 0 2628 AUDREY CANNAMELA EXECUTIVE DIRECTOR 40.00 X 104654 0 5532 JOSHUA MUSS SECRETARY 1.00 X X 0 0 0 FRANCINE LEVINSON TREASURER 1.00 X X 0 0 0 CECELIA SCORAH DIRECTOR 1.00 X 0 0 0 BRAD SPENCER DIRECTOR 1.00 X 0 0 0 278981 0 8160 2 0 1 0 MARCUM LLP 1899 L STREET NW SUITE 850 WASHINGTON DC 20036 ACCOUNTING/HR/TECH. SERVICES 126477 1 500581 500581 TREATMENT INCOME 900099 819501 819501 819501 9973 9973 765000 0 765000 765000 765000 2095055 765000 0 829474 X 287141 212985 74156 371148 342586 28562 11140 11037 103 10394 10394 61198 56148 5050 13200 13200 191024 166008 25016 683 341 342 62850 62400 450 46239 11551 34688 298 298 11931 10925 1006 15987 6382 9605 TREATMENT 60677 45116 15561 DISPOSAL OF FIXED ASSET 15408 15408 PROF. DEVELOPMENT 14823 14823 MEMBERSHIP DUES 1200 1200 1175341 967602 207739 0 212736 1484608 369113 429466 64504 0 48295 377465 377758 23215 0 1524794 1862366 298646 132 477931 48995 0 825572 132 X 699222 1862234 699222 1862234 1524794 1862366 X 919714 243298 X 0 0 0 X 39424 224561 199062 217570 500581 1181198 4386620 4030804 3806173 3729722 1584501 17537820 4426044 4255365 4005235 3947292 2085082 18719018 0 0 0 18719018 35466 16440 3187 3187 9973 68253 35466 16440 3187 3187 9973 68253 115 207 322 4461625 4271805 4008629 3950479 2095055 18787593 0.99630 0.99550 0.00360 0.00450 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2017 AMOUNT: $ 115. 2019 AMOUNT: $ 207. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 CERTIFICATES OF DEPOSIT 377758 F 377758 X X 0 0 0 0 0 0 0 0 0 DR HOWARD HOFFMAN PRESIDENT/CEO 174327 0 0 0 0 0 2134 0 494 0 176955 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE PRESIDENT/CEO REVIEWS THE DRAFT FEDERAL FORM 990 WITH THE EXECUTIVE COMMITTEE. THE FEDERAL FORM 990 IS THEN SIGNED AND FILED WITH THE INTERNAL REVENUE SERVICE. AFTER FINALIZATION, THE FINALIZED FORM 990 IS DISCUSSED AT THE NEXT MEETING OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C THE OFFICERS AND DIRECTORS ARE REQUIRED TO SIGN A DISCLOSURE FORM RELATED TO CONFLICTS OF INTEREST POLICY ON AN ANNUAL BASIS. THE DISCLOSURES ARE REVIEWED AND ANY POTENTIAL CONFLICTS ARE ADDRESSED ACCORDING TO THE FOUNDATION'S POLICY. 1. DUTY TO DISCLOSE. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS EITHER TO THE BOARD OF DIRECTORS OR TO MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. 2. DETERMINING WHETHER A CONFLICT OF INTEREST EXISTS AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE SHALL LEAVE THE BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON BY THE MEMBERS PRESENT. 3. PROCEDURES FOR ADDRESSING THE CONFLICT OF INTEREST A. AN INTERESTED PERSON MAY MAKE A PRESENTATION AT THE BOARD OF DIRECTOR'S MEETING, BUT AFTER THE PRESENTATION, HE/SHE SHALL LEAVE THE MEETING DURING THE DISCUSSION OF AND THE VOTE ON THE TRANSACTION OR ARRANGEMENT INVOLVING THE POSSIBLE CONFLICT OF INTEREST. B. THE PRESIDENT SHALL, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. IF THE POTENTIAL CONFLICT OF INTEREST INVOLVES THE PRESIDENT, THE TREASURER SHALL APPOINT AN INVESTIGATOR. ANY FINDINGS MADE BY THE APPOINTED INVESTIGATOR/COMMITTEE WILL BE PRESENTED TO THE BOARD OF DIRECTORS. C. AFTER EXERCISING DUE DILIGENCE, THE BOARD OF DIRECTORS SHALL DETERMINE WHETHER THE FOUNDATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. D. IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY POSSIBLE, THE BOARD OF DIRECTORS SHALL DETERMINE, BY A MAJORITY VOTE OF THE DISINTERESTED DIRECTORS, WHETHER THE TRANSACTION OR ARRANGEMENT IS IN THE FOUNDATION'S BEST INTEREST, FOR ITS OWN BENEFIT, AND WHETHER IT IS FAIR AND REASONABLE. IN CONFORMITY WITH THE ABOVE DETERMINATION IT SHALL MAKE ITS DECISION AS TO WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT. 4. VIOLATIONS OF THE CONFLICTS OF INTEREST POLICY A. IF THE BOARD OF DIRECTORS HAS REASONABLE CAUSE TO BELIEVE ANY PERSON HAS FAILED TO DISCLOSE ACTUAL OR POSSIBLE CONFLICTS OF INTEREST, IT SHALL INFORM THAT PERSON OF THE BASIS FOR SUCH BELIEF AND AFFORD THAT PERSON AN OPPORTUNITY TO EXPLAIN THE ALLEGED FAILURE TO DISCLOSE. B. IF, AFTER HEARING ANY RESPONSE AND AFTER MAKING FURTHER INVESTIGATION AS WARRANTED BY THE CIRCUMSTANCES, THE BOARD OF DIRECTORS DETERMINE THAT THE PERSON HAS FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, IT SHALL TAKE APPROPRIATE DISCIPLINARY AND CORRECTIVE ACTION. FORM 990, PART VI, SECTION B, LINE 15A THE FOUNDATION USES A COMPENSATION COMMITTEE, A WRITTEN EMPLOYMENT CONTRACT, REQUIRES APPROVAL BY THE BOARD OF DIRECTORS, AND HAS CONTEMPORANEOUS WRITTEN SUBSTANTIATION OF THE DECISION-MAKING PROCESS FOR DETERMINING CEO COMPENSATION. FOR THE EXECUTIVE DIRECTOR, THE PRESIDENT/CEO PRESENTS A SUMMARY OF THE EXECUTIVE DIRECTOR'S ACTIVITIES AND ACCOMPLISHMENTS TO THE BOARD OF DIRECTOR'S COMPENSATION COMMITTEE AND WILL MAKE A RECOMMENDATION FOR COMPENSATION FOR BOARD APPROVAL. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 166,008. MANAGEMENT AND GENERAL EXPENSES 25,016. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 191,024. FORM 990, PART XI, LINE 9: BAD DEBT REVERSAL 243,298.